Oppenheimer Reiterates Outperform Rating on Rhythm Pharmaceuticals (RYTM)
Go back to Oppenheimer Reiterates Outperform Rating on Rhythm Pharmaceuticals (RYTM)| (NASDAQ: RYTM) | Delayed: 100.26 +1.01 (1.02%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $99.25 | 52 Week High | $ | |||
| Open | $100.40 | 52 Week Low | $ | |||
| Day High | $101.39 | P/E | N/A | |||
| Day Low | $97.99 | EPS | $ | |||
| Volume | 119,607 | |||||
